Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-04-27

FDA Approved: MEXILETINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for mexiletine hydrochloride (Teva) to update its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mexiletine hydrochloride (mexiletine hydrochloride)

Snippet

SUPPL AP for MEXILETINE HYDROCHLORIDE (MEXILETINE HYDROCHLORIDE)